Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
P/E ratio for Establishment Labs Holdings Inc. (ESTA)
P/E ratio as of 2023: -8.44
According to Establishment Labs Holdings Inc.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -8.44. At the end of 2022 the company had a P/E ratio of -21.35.
P/E ratio history for Establishment Labs Holdings Inc. from 2016 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | -8.44 |
| 2022 | -21.35 |
| 2021 | -39.39 |
| 2020 | -23.02 |
| 2019 | -14.89 |
| 2018 | -22.55 |
| 2017 | -10.63 |
| 2016 | -20.65 |